Quarterly Updates6 Nov 2025, 08:33 pm
Sai Life Sciences Ltd. Announces Q2 and H1 Results for FY2025-26
AI Summary
Sai Life Sciences Ltd. has announced its unaudited financial results for the quarter and six months ended 30 September 2025. The company's revenue from operations stands at INR 5,266.69 million for Q2 and INR 10,097.07 million for H1. The net profit for Q2 is INR 1,413.19 million and INR 3,95.07 for H1. The earnings per equity share (basic) for Q2 is INR 3.97 and INR 9.00 for H1.
Key Highlights
- Revenue from operations for Q2 is INR 5,266.69 million and INR 10,097.07 for H1.
- Net profit for Q2 is INR 1,413.19 million and INR 3,95.07 for H1.
- Earnings per equity share (basic) for Q2 is INR 3.97 and INR 9.00 for H1.
- The company's standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
- The statutory auditors of the Company have issued an unmodified conclusion in respect of the limited review for the quarter and six months ended 30 September 2025.